Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
David Ladkani
Observed names:
D. LADKANI,
D. Ladkani,
DAVID LADKANI
Institution:
Teva Pharmaceuticals (Israel)
Observed institution:
Teva Pharmaceuticals (Israel)
OpenAlex ID:
A5113600977
Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double‐blind, placebo‐controlled trial
2007
·
Jerry S. Wolinsky
, Ponnada A. Narayana
, et al.
·
Annals of Neurology
·
456
PDF
Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study
2014
·
Anat Achiron
, Uri Givon
, et al.
·
Multiple Sclerosis Journal
·
96
PDF
Effects of glatiramer acetate on relapse rate and accumulated disability in multiple sclerosis: meta-analysis of three double-blind, randomized, placebo-controlled clinical trials
2003
·
Filippo Martinelli Boneschi
, Marco Rovaris
, et al.
·
Multiple Sclerosis Journal
·
88
The glatiramoid class of immunomodulator drugs
2009
·
Haim Varkony
, Vera Weinstein
, et al.
·
Expert Opinion on Pharmacotherapy
·
72
Long-term follow-up of patients treated with glatiramer acetate: a multicentre, multinational extension of the European/Canadian double-blind, placebo-controlled, MRI-monitored trial
2007
·
M. Rovaris
, G. Comi
, et al.
·
Multiple Sclerosis Journal
·
59
Copaxone’s effect on MRI-monitored disease in relapsing MS is reproducible and sustained
2002
·
J.S. Wolinsky
, G. Comi
, et al.
·
Neurology
·
49
Short-term correlations between clinical and MR imaging findings in relapsing-remitting multiple sclerosis.
2003
·
Marco Rovaris
, Giancarlo Comi
, et al.
·
PubMed Central
·
46
Alfacalcidol (Alpha D3) and Calcium in Osteoporosis
1994
·
J. MENCZEL
, J. FOLDES
, et al.
·
Clinical Orthopaedics and Related Research
·
46
Comparing the Biological Impact of Glatiramer Acetate with the Biological Impact of a Generic
2014
·
Fadi Towfic
, Jason M. Funt
, et al.
·
PLoS ONE
·
45
PDF
Randomized, double-blind, dose-comparison study of glatiramer acetate in relapsing–remitting MS
2007
·
J. A. Cohen
, M. Rovaris
, et al.
·
Neurology
·
45
Glatiramer acetate treatment in PPMS: Why males appear to respond favorably
2009
·
Jerry S. Wolinsky
, Tzippy Shochat
, et al.
·
Journal of the Neurological Sciences
·
42
Pharmacogenomics strategies to optimize treatments for multiple sclerosis: Insights from clinical research
2016
·
Iris Grossman
, Volker Knappertz
, et al.
·
Progress in Neurobiology
·
38
Effects of seasons on magnetic resonance imaging–measured disease activity in patients with multiple sclerosis
2001
·
Marco Rovaris
, Giancarlo Comi
, et al.
·
Annals of Neurology
·
34
Nucleophilic attacks on carbon–carbon double bonds. Part XX. Reaction of active methylene compounds with electrophilic olefins. Formation of substituted 2-amino-4-cyano-4H-pyrans
1974
·
Zvi Rappoport
, David Ladkani
·
Journal of the Chemical Society Perkin Transactions 1
·
32
Functional effects of the antigen glatiramer acetate are complex and tightly associated with its composition
2015
·
Tal Hasson
, Sarah Kolitz
, et al.
·
Journal of Neuroimmunology
·
23
PDF
Cost-effectiveness analysis of glatiramer acetate in the treatment of relapsing-remitting multiple sclerosis
2001
·
Uday Bose
, David Ladkani
, et al.
·
Journal of Medical Economics
·
22
PDF
Gene expression studies of a human monocyte cell line identify dissimilarities between differently manufactured glatiramoids
2015
·
Sarah Kolitz
, Tal Hasson
, et al.
·
Scientific Reports
·
19
PDF
Phase transfer catalysis in N‐alkylation of the pharmaceutical intermediates phenothiazine and 2‐chlorophenothiazine
1984
·
Igal Gozlan
, David Ladkani
, et al.
·
Journal of Heterocyclic Chemistry
·
15
Phase transfer catalysis in N‐alkylations of the pharmaceutical intermediates 5H‐dibenz[b,f]azepine and 5H‐10,11‐dihydrodibenz[b,f]azepine
1982
·
Igal Gozlan
, Marc Halpern
, et al.
·
Journal of Heterocyclic Chemistry
·
14
Nucleophilic attacks on carbon–carbon double bonds. Part XVIII. Reaction of 2-dicyanomethyleneindane-1,3-dione with anilines in acetonitrile
1973
·
Zvi Rappoport
, David Ladkani
·
Journal of the Chemical Society Perkin Transactions 2
·
13
Pharmacokinetic analysis of diethylcarbonate prodrugs of ibuprofen and naproxen
1995
·
Emil Samara
, David Avnir
, et al.
·
Biopharmaceutics & Drug Disposition
·
12
Once‐daily glatiramer acetate decreases magnetic resonance imaging disease activity in Japanese patients with relapsing–remitting multiple sclerosis
2017
·
Takashi Yamamura
, Natalia Ashtamker
, et al.
·
Clinical and Experimental Neuroimmunology
·
5
PDF
Effect of Alfacalcidol on Fatigue in MS Patients: A Randomized, Double-Blind Study (S23.004)
2014
·
Yoram Barak
, David Magalashvili
, et al.
·
Neurology
·
3
Pharmacokinetic analysis of valdice — a diethylcarbonate prodrug of valproic acid
1994
·
Meir Bialer
, Zharura Pharaj
, et al.
·
European Journal of Pharmaceutical Sciences
·
3
Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree
2016
·
Gary R. Cutter
, Volker Knappertz
, et al.
·
BMC Neurology
·
2
PDF
Show more works
View as search
Works count:
36
Citation count:
1,283
H-index:
17
I10-index:
21
Year
Topic
Type